Quvium has developed CoughAware, a wearable device that can predict an impending asthma attack of its wearer. The device, which is being tested in the United States, uses sensors to detect changes in air quality and barometric pressure as well as heart rate variability during exercise. A case study found that the device, which can also be used for patients with cystic fibrosis and people with chronic obstructive pulmonary disease, decreased the yearly number of times children with asthma missed school and visited hospital.
Quvium has developed CoughAware, a wearable device that can predict an impending asthma attack of its wearer. The aim of this technology is to prompt the wearer to act early to prevent the attacks and lower the number of asthma-related deaths. A case study found that the device, which can also be used for patients with cystic fibrosis and people with chronic obstructive pulmonary disease, decreased the yearly number of times children with asthma missed school and visited hospital.